語(yǔ)言版本選擇
English
簡(jiǎn)體中文
KEY PRODUCTS
CTTQ manufactures over 50 prescription medicines in 5 core therapeutic areas.
| Product | Current Status | Specification |
|---|---|---|
| Amifostine | USDMF: 21765 | USP |
| Bendamustine HCl | USDMF: 27018 | In-House |
| Colistimethate Sodium | CEP: 2015-189 | EP / USP |
| Fosaprepitant Dimeglumine | USDMF: 28288 | In-House |
| Foscarnet Sodium | USDMF: 29056 | EP / USP |
| Fulvestrant | DMF under preparation | In-House |
| Products under evaluation |
|---|
| Degarelix Acetate |
| Everolimus |
| Gadoteridol |
| Gadoxetate Disodium |
| Ibrutinib |
| The above mentioned products are not available in countries where valid patents exist. |